2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

By Cardiometabolic Health Congress (CMHC) FEATURING Salim Virani

896 views

September 22, 2020

0 Comments

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Ambulatory Blood Pressure Monitoring

26:11

13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason

42:28

Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff

18:43

Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue

59:01

The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross

19:16

The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez

21:34

Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker

24:02

Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus

19:24

National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg

08:44

AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston

21:27

Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta

14:50

AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray

19:09

ACC 2023 Conference Coverage

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

Feat. J. Saseen

34:20

Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester

45:45

Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald

28:05

Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

31:02

Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar

19:20

National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne

Login

Login

Join VuMedi

2020 Update on Lipid Lowering Therapy in ASCD: What Medications Are Available to Address Residual Risk of in Statin Treated Patients? What Do the Treatment Guidelines Define as High-Risk Patients in Primary Prevention?

Related Content